Cargando…

Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer

Detalles Bibliográficos
Autores principales:	Tolba, Mai F., Santa-Maria, Cesar A., Albini, Adriana, Chimusa, Emile R., Al-Ramadi, Basel K., Tolaney, Sara M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651555/ https://www.ncbi.nlm.nih.gov/pubmed/34900701 http://dx.doi.org/10.3389/fonc.2021.752689

Ejemplares similares

Editorial: The Evolving Role of Immunotherapy in Non-Melanoma Skin Cancers
por: Guida, Michele, et al.
Publicado: (2022)

The IL-6/STAT3 Signaling Pathway Is an Early Target of Manuka Honey-Induced Suppression of Human Breast Cancer Cells
por: Aryappalli, Priyanka, et al.
Publicado: (2017)

Attenuated Bacteria as Immunotherapeutic Tools for Cancer Treatment
por: Kaimala, Suneesh, et al.
Publicado: (2018)

Editorial: Advancements in immunology and immunotherapy for breast cancer
por: Sugie, Tomoharu, et al.
Publicado: (2022)

Editorial: Emerging engineering approaches in cancer immunotherapy
por: Xu, Jialu, et al.
Publicado: (2022)

Immunotherapy for the Treatment of Triple-Negative Breast Cancer
por: Tolaney, Sara M., et al.
Publicado: (2022)

Editorial: Evolving roles of piRNAs in solid tumors
por: Ng, Lui, et al.
Publicado: (2023)

Editorial: Immunotherapy in Hepatocellular Carcinoma
por: Li, Bin, et al.
Publicado: (2021)

Editorial: Personalized immunotherapy for cancer
por: Pasetto, Anna, et al.
Publicado: (2023)

Editorial: The role of immunotherapy in melanomas
por: Fateeva, Anna, et al.
Publicado: (2023)

Editorial: Exploring the breast tumor microenvironment: Association to metastasis, novel risk factors and novel treatments and immunotherapies
por: Nava-Castro, Karen Elizabeth, et al.
Publicado: (2022)

Editorial: Optimizing outcomes and addressing adversities of immunotherapy in lung cancer
por: Al-Rajabi, Taiseer, et al.
Publicado: (2023)

Editorial: Advances in Combination Tumor Immunotherapy
por: Curran, Michael A., et al.
Publicado: (2015)

Editorial: The Biological Landscape of Immunotherapy in AML
por: Isidori, Alessandro, et al.
Publicado: (2021)

Editorial: Epigenetic Regulation and Tumor Immunotherapy
por: Sun, Hongyin, et al.
Publicado: (2022)

Editorial: Immunotherapy in renal cell carcinoma
por: Gruenwald, Viktor, et al.
Publicado: (2022)

Editorial: Engineered Targeted Cancer Immunotherapies
por: Fantini, Massimo, et al.
Publicado: (2022)

Editorial: Impact of immunotherapy in lung cancer
por: Ferreira, Marion, et al.
Publicado: (2022)

Editorial: Microbiota and metabolites in cancer immunotherapy
por: Roviello, Giandomenico, et al.
Publicado: (2022)

Editorial: Imaging assessment of response to immunotherapy
por: Occhipinti, Mariaelena, et al.
Publicado: (2023)

Editorial: New Approaches to Breast Cancer Radiotherapy
por: Jacobson, Geraldine Meerbott, et al.
Publicado: (2021)

Editorial: The Evolving Landscape of Stereotactic Body Radiation Therapy for the Management of Prostate Cancer
por: Blacksburg, Seth R., et al.
Publicado: (2020)

Editorial: The Evolving Landscape, Clinical Implications, and Future Perspective of Biomarkers in Gastrointestinal Cancers
por: Tsai, Hsiang-Lin, et al.
Publicado: (2022)

Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy
por: Santich, Brian H., et al.
Publicado: (2020)

Editorial: Immunology and Immunotherapy of Head and Neck Cancer
por: Gavrielatou, Niki, et al.
Publicado: (2021)

Editorial: Immunotherapy for NSCLC with oncogenic driver variants
por: Du, Yijia, et al.
Publicado: (2022)

Editorial: Tumor microenvironment, inflammation, and resistance to immunotherapies
por: Decock, Julie, et al.
Publicado: (2023)

Tumor mutational burden as a predictor of immunotherapy response in breast cancer
por: O’Meara, Tess A., et al.
Publicado: (2021)

Editorial: Advances in Head and Neck Cancer Immunology and Immunotherapy
por: Abu Eid, Rasha
Publicado: (2019)

Editorial: Targeting tumor vasculature to enhance cancer immunotherapy
por: Yang, Jieying, et al.
Publicado: (2023)

Editorial: Biomarkers and immunotherapy of hepatic-biliary-pancreatic cancers
por: Qian, Yawei, et al.
Publicado: (2023)

Editorial: Genomics and Epigenomics of Cancer Immunotherapy: Challenges and Clinical Implications
por: Abedalthagafi, Malak
Publicado: (2021)

Editorial: Biomarkers of Immune-Checkpoint-Inhibitor Immunotherapies in Hepatocellular Carcinomas
por: Guo, Zhanjun, et al.
Publicado: (2022)

Editorial: Mechanisms of resistance to the targeted therapy and immunotherapy in cutaneous melanoma
por: Premi, Sanjay, et al.
Publicado: (2022)

Editorial: Novel immunotherapies to treat gastrointestinal solid tumor cancers
por: Sureban, Sripathi M., et al.
Publicado: (2022)

Editorial: The interconnection between the tumor microenvironment and immunotherapy in brain tumors
por: Qu, Chunrun, et al.
Publicado: (2023)

Editorial: Tailoring immunotherapy in gastrointestinal cancer: the role of circulating factors
por: Ugel, Stefano, et al.
Publicado: (2023)

Editorial: Drug resistance in breast cancer – mechanisms and approaches to overcome chemoresistance
por: Raman, Dayanidhi, et al.
Publicado: (2023)

Editorial: Surgical approaches for the treatment of glioma
por: La Rocca, G., et al.
Publicado: (2022)

Editorial: Immunotherapy for Tumor in the Brain: Insights From—and For—Other Tumor Sites
por: Lampson, Lois A.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1rj0pcj65st5iq464b904aofpd